niceritrol has been researched along with Impotence in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is recommended for patients with hyperlipemia alone, or those who suffer from combined erectile dysfunction." | 2.67 | [The clinical effect of slow releasing nicotinate on hyperlipemic impotent patients]. ( Hwang, TI; Yang, CR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, TI | 1 |
| Yang, CR | 1 |
1 trial available for niceritrol and Impotence
| Article | Year |
|---|---|
[The clinical effect of slow releasing nicotinate on hyperlipemic impotent patients].
Topics: Delayed-Action Preparations; Erectile Dysfunction; Humans; Hyperlipidemias; Male; Niceritrol; Single | 1993 |